By — John Yang John Yang By — Andrew Corkery Andrew Corkery Leave your feedback Share Copy URL https://www.pbs.org/newshour/show/investigation-raises-concerns-about-lack-of-fda-quality-testing-for-generic-drugs Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter Transcript Audio By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug Administration says that all agency-approved generic drugs “have the same high quality” as brand-name drugs, but a ProPublica investigation found that the FDA rarely tests the quality of generic drugs. John Yang speaks with investigative reporter Debbie Cenziper for more. Read the Full Transcript Notice: Transcripts are machine and human generated and lightly edited for accuracy. They may contain errors. John Yang: By some estimates, about 90 percent of all prescriptions in the United States are filled with generic drugs. Insurance companies encourage their use over brand name medications to reduce health care costs. The Food and Drug Administration says that all agency approved generic drugs have the same high quality, strength, purity and stability. As brand name drugs.But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors of that investigation.Debbie, the FDA doesn't test these drugs, but you independently tested some of the most widely used generic drugs. What did you find? Debbie Cenziper, National Reporter, ProPublica: Yeah, we did because the FDA isn't regularly testing drugs. And what we found in this testing is that there were certain versions of widely prescribed generic drugs that had concerning results because they didn't dissolve properly in the body. John Yang: Have patients or other people expressed concerns about this in the past? Debbie Cenziper: Absolutely, and it's one of the reasons we did the testing in the first place. And that is because doctors, pharmacists, consumers, academic researchers, even the Department of Defense has raised concerns about the quality of some of our generic drugs.And despite all of that, the FDA does not have a regular testing program. The agency doesn't regularly test for quality and safety issues. John Yang: Do they do that with brand name medications? Debbie Cenziper: No. I mean, the FDA publicly reports the names of the drugs that they test, including brand name drugs and over the counter drugs, but there's no regular testing program. They say they test based on risk, but what we found is that they're not regularly testing drugs coming in from some of the most troubled factories overseas. John Yang: What's the FDA's rationale for this? Debbie Cenziper: The FDA just by just didn't think it would work right, because they would only be testing a sample, a small sample, a moment in time, and it wouldn't necessarily pick up on trends and wider concerns. But the Department of Defense is now testing 40 or so drugs because they are concerned about contaminants and other things that can go wrong. Not all generics are the same as brand name drugs, and doctors and patients have been saying that for years. John Yang: Talk about what patients are saying. Have there been specific cases where people have said that the generic doesn't feel the same as the brand name or that they wonder about the effects? Debbie Cenziper: Absolutely. And that's really what struck us as reporters, is how many people just turn to social media and say, something's not right with this drug. One of the drugs we had tested was bupropion. It's antidepressant. And so many people for so many years have been saying when they switch from the brand Wellbutrin to a generic or from one version of a generic to another, they get all kinds of funny symptoms or worse, they just feel the drug is ineffective.And doctors might say, well, meaning doctors who are busy might say, something's wrong with, it's just you, it's your body, or it's Mother Nature or it's God, or it's bad luck. But it actually might be that drug, that version doesn't work the same as the brand. And for too long, we haven't really been asking those questions. John Yang: In addition to testing these generics yourself or the ProPublica doing it, you've also created a tool where people can check what's in their medicine cabinets. Tell us about that. Debbie Cenziper: We really at ProPublica wanted to empower consumers to take control of their own health care by creating a tool. It's free, it's a lookup tool. It's called RX Inspector, where you can actually take the information on the labels of your pill bottle, stick it in this tool, figure out where your drugs were made the factory that made it and whether that factory has ever been in trouble with the FDA for substandard manufacturing practices. John Yang: And where do people go to get this tool? Debbie Cenziper: Right on ProPublica's website, we're free. It's called RX Inspector. But I think it's important to note that even if you find something, a bad inspection for a factory that makes your drug, it doesn't necessarily mean that your generic is unsafe and that you should stop taking the drug. Right. I mean, you should always talk to your health care provider.But we really felt like this was information that had never been made public before, not by the FDA and not by the drug makers themselves. And so we spent many months putting this tool together for consumers. John Yang: Debbie Cenziper of ProPublica, thank you very much. Debbie Cenziper: Thank you for having me. Listen to this Segment Watch Watch the Full Episode PBS NewsHour from Jan 11, 2026 By — John Yang John Yang John Yang is a correspondent for the PBS News Hour. He covered the first year of the Trump administration and is currently reporting on major national issues from Washington, DC, and across the country. @johnyangtv By — Andrew Corkery Andrew Corkery Andrew Corkery is a national affairs producer at PBS News Weekend.